Crossmark

Difference in the cumulative incidence of aneurysmal occlusion by Flow Re-direction Endoluminal Device and Pipeline Embolization Device in the treatment of unruptured internal carotid artery aneurysms: a propensity score-matched cohort study

Crossref DOI link: https://doi.org/10.1007/s10143-023-02026-z

Published Online: 2023-05-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsukawa, Hidetoshi

Uchida, Kazutaka

Rajbhandari, Saujanya

Shirakawa, Manabu

Yoshimura, Shinichi
License Information

Text and Data Mining valid from 2023-05-27

Version of Record valid from 2023-05-27
More Information

Article History

Received: 4 April 2023

Revised: 24 April 2023

Accepted: 6 May 2023

First Online: 27 May 2023

Declarations

:

: The authors declare no competing interests.

: The study protocol was approved by the institutional ethics committee (No. 3229).

: H. Matsukawa received a lecture fee from Daiichi-Sankyo and consulting services fee from B. Braun. K. Uchida received a lecture fee from Daiichi-Sankyo, Bristol-Myers Squibb, Stryker, and Medtronic. S. Yoshimura received a lecture fee from Stryker, Medtronic, Johnson & Johnson, and Kaneka Medics. The remaining authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below